Royal Orchid Hotels Ltd
ROHLTDRoyal Orchid Hotels Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: Foreign institutions moved +2.1 points over 8 quarters while the operating story went the other way — someone close to the numbers is not convinced.
The price is in a downtrend (37 weeks in) while the P/E sits at the 83rd percentile of its own 8-year range. Underneath, the last four quarters read deteriorating — profit −39.3% year on year, and 127% of the last 3 years' profit arrived as cash. What settles it: whether the register turns back in the story’s favour.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Royal Orchid Hotels Ltd trades at ₹306, in a downtrend and 37 weeks into that stage. That is −10.9% against its own 200-day average. It sits at 7% of a 52-week range of ₹291 to ₹513. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (14 weeks and counting).
Today the stock is in a downtrend — week 37 of stage 4, confirmed. At ₹306 it trades −10.9% versus its 200-day average and sits at 7% of its 52-week range (₹291–₹513).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +326% while the NIFTY 500 moved +267% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (14 weeks and counting; last ahead the week of 2026-06-19) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Royal Orchid Hotels Ltd trades at 31.5× P/E, at the pricey end of its own range (83rd percentile). Its long-run median P/E is 22.6×, measured across 8.0 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 31.5× is at the pricey end of its own range (83rd percentile), against a long-run median of 22.6× measured over 8.0 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved −31.9% against a −39.4% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 3y, of the +0.9%/yr price move, ~−16.5%/yr came from earnings growth and ~+17.4 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 13 June 2026 price, Royal Orchid Hotels Ltd was paying for profit growth of about 16.7% a year. Today the market pays 31.5× P/E, the 83rd percentile of its own 8-year range.
What the two numbers say together. The multiple is full against its own past, and the growth the price is paying for is the whole of what a buyer is backing.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Royal Orchid Hotels Ltd reads as deteriorating on its fundamental arc. Deteriorating — profit and EPS growth are shrinking (profit growth −42.1% latest against +8.0% at its 12-quarter best), ROCE slipping at 11.0%. The read is built from 8 quarters across 4 curves, on partial evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +20.4% | +13.3% | +36.5% | +9.2% |
| Profit | −29.8% | −12.3% | — | — |
| EPS | −31.9% | −11.9% | — | — |
| Share price | −39.4% | +0.9% | +31.6% | +17.0% |
4-Factor Sector Score
37.7/100 — rank 22 of 24 in Hotels · 81% evidence confidence
Royal Orchid Hotels Ltd scores 37.7 out of 100 against the 24 companies it is compared with in Hotels, ranking 22. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 12.5 + 11.9 + 7.9 + 5.4 = 37.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Royal Orchid Hotels Ltd reported ₹107 Cr of revenue in the Jun 26 quarter, +36.1% year on year. That is the 11th straight quarter of year-on-year growth. Over 10 years it has compounded at 9.2% a year. The last full year, FY26, came in at ₹384 Cr. The last four reported quarters add to ₹413 Cr.
FY26 revenue came in at ₹384 Cr (+20.4% on the year), capping 10 years at 9.2% compound. The latest quarter (Jun 26) printed ₹107 Cr, +36.1% year on year — the 11th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +26.4% growth against the decade's 9.2% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +26.9% over the last 4 quarters against +17.7%/yr over the last 8 — accelerating; TTM profit −42.1% vs −23.0%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Royal Orchid Hotels Ltd's operating margin is 23.7% in the Jun 26 quarter, −1.2 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −14.0% to 31.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 23.7%, −1.2 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −14.0%–31.0%.
🚨 Why the margin moved: operating margin went −1.2 pp year on year while gross margin went +1.2 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Royal Orchid Hotels Ltd earned ₹6.8 Cr of net profit in the Jun 26 quarter, −39.3% year on year. Full-year FY26 profit was ₹33.0 Cr. That is 6.3% of the quarter's revenue. The same quarter a year earlier earned ₹11.2 Cr.
Jun 26 profit was ₹6.8 Cr, −39.3% year on year. On the full year, FY26 printed ₹33.0 Cr (−29.8%).
🚨 Why profit moved: revenue contributed +36.1% and the margin −1.2 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit −41.6% vs revenue +26.4%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 127% of Royal Orchid Hotels Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹82.0 Cr of operating cash against ₹33.0 Cr of profit. After ₹498 Cr of capital spending, ₹−416 Cr was left as free cash.
FY26: operating cash of ₹82.0 Cr against reported profit of ₹33.0 Cr, leaving free cash of ₹−416 Cr after ₹498 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 127% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 127%: the cash cycle stretched 649 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: the bigger cash user is investment — capital spending ran 7.8× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Royal Orchid Hotels Ltd's cash conversion cycle runs −357 days in FY26, up from −1,006 days in FY21. Capital spending ran ₹602 Cr over the last 3 years. At FY26 sales of ₹384 Cr each day of that cycle holds about ₹1.1 Cr, so roughly ₹−376 Cr sits inside the business at any moment.
FY26: debtors at 36 days, inventory at 32 days — roughly 1.1 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of −357 days, looser than FY21's −1,006.
The full loop: cash goes out to suppliers and production on day 0; stock waits 32 days to sell; customers pay about 36 days after that; and suppliers themselves are paid at 425 days — netting out to the −357-day cycle.
In money terms: at FY26 sales of ₹384 Cr, each day of the cycle holds about ₹1.1 Cr — so the −357-day loop keeps roughly ₹−376 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹602 Cr over the last 3 fiscal years against ₹77.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹2.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
Royal Orchid Hotels Ltd earns a ROCE of 11% in FY26. That is up from a trough of −6% in FY21. Return on invested capital clears the cost of that capital by −5.3 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 8.6% net margin on 0.37× asset turns.
FY26 ROCE is 11%, recovered from a FY21 trough of −6% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 8.6% net margin × 0.37× asset turns × 4.04× balance-sheet leverage ≈ 12.9% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 6.7% − 12.0% = a −5.3 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
Royal Orchid Hotels Ltd carries total debt of ₹641 Cr against shareholder equity of ₹276 Cr as of Mar 26, a debt-to-equity of 2.32. On the annual view that ratio went from 1.01 in FY22 to 2.32 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹641 Cr against shareholder equity of ₹276 Cr — a debt-to-equity of 2.32. On the annual view, debt-to-equity went from 1.01 (FY22) to 2.32 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Foreign institutions added 2.1 points of Royal Orchid Hotels Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 8.6% of the company. Promoters moved +0.4 points over the same window, to 64.1%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: +2.1 points over 8 quarters to 8.6%; Promoters: +0.4 points over 8 quarters to 64.1%; Domestic institutions: +0.2 points over 8 quarters to 0.9%.
Why the register moved: foreign institutions drove it (+2.1 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Royal Orchid Hotels Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Chalet Hotels LtdCHALET | 71.3/100Favorable setup94% evidence | BREAKING OUT | 25.4/35 Revenue 6% · PAT 85.3% · OPM change 6 pp 100% evidence | 15.9/25 ROCE 17% · OPM 46% 100% evidence | 16.1/20 P/E 35.9× · PEG 0.83 100% evidence | 13.9/20 RS sector 3.6% · RS bench 4.9% · 1Y -14.1%4 of 10 weeks ahead 70% evidence |
| Exact sum: 25.4 + 15.9 + 16.1 + 13.9 = 71.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Asian Hotels (West) LtdAHLWEST | 66.2/100Favorable setup74% evidence | ASLEEP | 26.6/35 Revenue 8.5% · PAT 100% · OPM change 2 pp 95% evidence | 19.9/25 ROCE 19.7% · OPM 40% 95% evidence | 11.4/20 P/E 6.5× · PEG — 15% evidence | 8.3/20 RS sector -25% · RS bench 35.5% · 1Y —5 of 10 weeks ahead 70% evidence |
| Exact sum: 26.6 + 19.9 + 11.4 + 8.3 = 66.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Oriental Hotels LtdORIENTHOT | 62.7/100Mixed-positive evidence93% evidence | LEADER | 17.4/35 Revenue 6.9% · PAT 41.1% · OPM change -2.8 pp 100% evidence | 11.4/25 ROCE 12.1% · OPM 21% 100% evidence | 14.0/20 P/E 37.6× · PEG 0.66 65% evidence | 19.9/20 RS sector 24.4% · RS bench 25.2% · 1Y 0.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 17.4 + 11.4 + 14 + 19.9 = 62.7 · Decision use: Price leads the evidence: RS versus the benchmark is 25.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 4Indian Hotels Co LtdINDHOTEL | 61.3/100Mixed-positive evidence82% evidence | BREAKING OUT | 20.2/35 Revenue 13.2% · PAT 9.5% · OPM change 1 pp 95% evidence | 17.1/25 ROCE 17.1% · OPM 29% 76% evidence | 10.1/20 P/E 52.6× · PEG — 50% evidence | 13.9/20 RS sector 3.7% · RS bench 4.7% · 1Y -7.3%10 of 12 weeks ahead 100% evidence |
| Exact sum: 20.2 + 17.1 + 10.1 + 13.9 = 61.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Leela Palaces Hotels & Resorts LtdTHELEELA | 59.9/100Mixed-positive evidence93% evidence | LEADER | 24.6/35 Revenue 19.1% · PAT 100% · OPM change -1 pp 100% evidence | 9.3/25 ROCE 8.7% · OPM 36% 100% evidence | 7.6/20 P/E 40.4× · PEG 1.65 65% evidence | 18.4/20 RS sector 21.4% · RS bench 22.8% · 1Y 32%12 of 12 weeks ahead 100% evidence |
| Exact sum: 24.6 + 9.3 + 7.6 + 18.4 = 59.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Travel Food Services LtdTRAVELFOOD | 58.1/100Mixed-positive evidence69% evidence | FADING | 16.2/35 Revenue 4.4% · PAT 17.4% · OPM change -3 pp 95% evidence | 21.2/25 ROCE 42.4% · OPM 36% 76% evidence | 9.5/20 P/E 34.7× · PEG — 15% evidence | 11.2/20 RS sector -0.2% · RS bench 0.8% · 1Y -4.2%3 of 12 weeks ahead 70% evidence |
| Exact sum: 16.2 + 21.2 + 9.5 + 11.2 = 58.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7TajGVK Hotels & Resorts LtdTAJGVK | 56.4/100Mixed-positive evidence87% evidence | FADING | 21.3/35 Revenue 22.5% · PAT 100% · OPM change 0 pp 100% evidence | 12.9/25 ROCE 13.3% · OPM 30% 100% evidence | 14.3/20 P/E 14.6× · PEG 0.85 65% evidence | 7.9/20 RS sector -3.6% · RS bench -6.5% · 1Y -24.2%6 of 11 weeks ahead 70% evidence |
| Exact sum: 21.3 + 12.9 + 14.3 + 7.9 = 56.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Benares Hotels LtdBENARAS | 52.8/100Mixed-positive evidence76% evidence | 9.1/35 Revenue 7.7% · PAT -1.1% · OPM change -3.3 pp 95% evidence | 21.0/25 ROCE 29.8% · OPM 36.9% 76% evidence | 6.8/20 P/E 32.7× · PEG — 50% evidence | 15.9/20 RS sector 12.1% · RS bench 14.3% · 1Y 18.8%4 of 12 weeks ahead 70% evidence | |
| Exact sum: 9.1 + 21 + 6.8 + 15.9 = 52.8 · Decision use: Price leads the evidence: RS versus the benchmark is 14.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 9Juniper Hotels LtdJUNIPER | 52.4/100Mixed-positive evidence93% evidence | TURNING | 23.3/35 Revenue 11.4% · PAT 100% · OPM change -1 pp 100% evidence | 6.4/25 ROCE 8% · OPM 35% 100% evidence | 10.3/20 P/E 26.5× · PEG 1.48 65% evidence | 12.4/20 RS sector -1.7% · RS bench -1.2% · 1Y -23.8%2 of 12 weeks ahead 100% evidence |
| Exact sum: 23.3 + 6.4 + 10.3 + 12.4 = 52.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Lemon Tree Hotels LtdLEMONTREE | 51.0/100Mixed-positive evidence69% evidence | BASING | 18.9/35 Revenue 10.4% · PAT 9.6% · OPM change -1 pp 95% evidence | 16.4/25 ROCE 14.1% · OPM 43% 76% evidence | 9.9/20 P/E 32.4× · PEG — 15% evidence | 5.8/20 RS sector -8.5% · RS bench -18.2% · 1Y -40.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 18.9 + 16.4 + 9.9 + 5.8 = 51 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11ITC Hotels LtdITCHOTELS | 50.8/100Mixed-positive evidence93% evidence | BREAKING OUT | 23.4/35 Revenue 16.1% · PAT 26.9% · OPM change 1 pp 100% evidence | 10.7/25 ROCE 11.2% · OPM 31% 100% evidence | 11.2/20 P/E 34.7× · PEG 1.15 65% evidence | 5.5/20 RS sector -13.7% · RS bench -13.3% · 1Y -37%3 of 12 weeks ahead 100% evidence |
| Exact sum: 23.4 + 10.7 + 11.2 + 5.5 = 50.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -13.7% and the one-year return is -37%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 12Kamat Hotels (India) LtdKAMATHOTEL | 48.5/100Mixed-negative evidence81% evidence | BREAKING OUT | 13.4/35 Revenue 7.6% · PAT -11.5% · OPM change 5.3 pp 95% evidence | 16.9/25 ROCE 15.8% · OPM 27.2% 95% evidence | 10.6/20 P/E 15.8× · PEG — 50% evidence | 7.6/20 RS sector -20.6% · RS bench 7.5% · 1Y -29.3%7 of 11 weeks ahead 70% evidence |
| Exact sum: 13.4 + 16.9 + 10.6 + 7.6 = 48.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Advent Hotels International LtdADVENTHTL | 46.3/100Mixed-negative evidence60% evidence | TURNING | 16.7/35 Revenue 3.5% · PAT -29.3% · OPM change 6.1 pp 95% evidence | 8.5/25 ROCE 6.8% · OPM 32.6% 95% evidence | 11.1/20 P/E 14.3× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead 0% evidence |
| Exact sum: 16.7 + 8.5 + 11.1 + 10 = 46.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14EIH LtdEIHOTEL | 46.2/100Mixed-negative evidence82% evidence | BASING | 12.1/35 Revenue 8.3% · PAT 4.2% · OPM change -3 pp 95% evidence | 18.3/25 ROCE 20.7% · OPM 25% 76% evidence | 13.3/20 P/E 24.7× · PEG — 50% evidence | 2.5/20 RS sector -14.2% · RS bench -13.6% · 1Y -30.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 12.1 + 18.3 + 13.3 + 2.5 = 46.2 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 15U P Hotels LtdUPHOT | 46.1/100Mixed-negative evidence76% evidence | 7.1/35 Revenue 1.4% · PAT -6% · OPM change -6.5 pp 95% evidence | 16.5/25 ROCE 21.7% · OPM 11.2% 76% evidence | 10.9/20 P/E 25.6× · PEG — 50% evidence | 11.6/20 RS sector 1.2% · RS bench -0.1% · 1Y -14.1%0 of 12 weeks ahead 70% evidence | |
| Exact sum: 7.1 + 16.5 + 10.9 + 11.6 = 46.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Ventive Hospitality LtdVENTIVE | 45.5/100Mixed-negative evidence75% evidence | BASING | 20.9/35 Revenue 25% · PAT 100% · OPM change -6 pp 95% evidence | 12.3/25 ROCE 10.8% · OPM 35% 76% evidence | 10.1/20 P/E 27.7× · PEG — 15% evidence | 2.2/20 RS sector -14% · RS bench -13.3% · 1Y -20.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.9 + 12.3 + 10.1 + 2.2 = 45.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Asian Hotels (North) LtdASIANHOTNR | 42.9/100Thin evidence · provisional56% evidence | TURNING | 14.0/35 Revenue 24.7% · PAT -80% · OPM change -3.6 pp 44% evidence | 4.5/25 ROCE 3.5% · OPM 17.5% 95% evidence | 8.5/20 P/E 120× · PEG — 15% evidence | 15.9/20 RS sector 8.5% · RS bench 23.3% · 1Y 15%2 of 10 weeks ahead 70% evidence |
| Exact sum: 14 + 4.5 + 8.5 + 15.9 = 42.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Samhi Hotels LtdSAMHI | 42.7/100Mixed-negative evidence83% evidence | ASLEEP | 19.2/35 Revenue 11.9% · PAT 100% · OPM change -1 pp 100% evidence | 6.5/25 ROCE 8.9% · OPM 32% 100% evidence | 11.2/20 P/E 8.3× · PEG — 15% evidence | 5.8/20 RS sector -8.1% · RS bench -7.5% · 1Y -27.6%7 of 12 weeks ahead 100% evidence |
| Exact sum: 19.2 + 6.5 + 11.2 + 5.8 = 42.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Sayaji Hotels LtdSAYAJIHOTL | 42.2/100Mixed-negative evidence63% evidence | BREAKING OUT | 12.7/35 Revenue -8.6% · PAT 79.7% · OPM change 3.3 pp 71% evidence | 4.3/25 ROCE -0.5% · OPM 13.3% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 15.2/20 RS sector 8.5% · RS bench 11.3% · 1Y 8%8 of 11 weeks ahead 70% evidence |
| Exact sum: 12.7 + 4.3 + 10 + 15.2 = 42.2 · Decision use: Price leads the evidence: RS versus the benchmark is 11.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 20Viceroy Hotels LtdVHLTD | 40.0/100Mixed-negative evidence79% evidence | ASLEEP | 20.7/35 Revenue 24.4% · PAT -69.2% · OPM change 10.8 pp 71% evidence | 8.0/25 ROCE 7.1% · OPM 25.6% 95% evidence | 7.8/20 P/E 40.1× · PEG — 50% evidence | 3.5/20 RS sector -10.1% · RS bench -4% · 1Y 2.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.7 + 8 + 7.8 + 3.5 = 40 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21EIH Associated Hotels LtdEIHAHOTELS | 38.5/100Mixed-negative evidence87% evidence | BASING | 7.2/35 Revenue -7.6% · PAT -7% · OPM change -2.2 pp 95% evidence | 14.6/25 ROCE 21.2% · OPM 10.8% 95% evidence | 13.4/20 P/E 19.5× · PEG — 50% evidence | 3.3/20 RS sector -13.4% · RS bench -12.7% · 1Y -29.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 7.2 + 14.6 + 13.4 + 3.3 = 38.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 22Royal Orchid Hotels Ltdthis pageROHLTD | 37.7/100Mixed-negative evidence81% evidence | BASING | 12.5/35 Revenue 26.9% · PAT -42.1% · OPM change -1.2 pp 95% evidence | 11.9/25 ROCE 10.8% · OPM 23.7% 95% evidence | 7.9/20 P/E 31.5× · PEG — 50% evidence | 5.4/20 RS sector -9.8% · RS bench -16.4% · 1Y -43.6%0 of 10 weeks ahead 70% evidence |
| Exact sum: 12.5 + 11.9 + 7.9 + 5.4 = 37.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Apeejay Surrendra Park Hotels LtdPARKHOTELS | 32.1/100Adverse evidence87% evidence | BASING | 12.3/35 Revenue 10.5% · PAT -36.4% · OPM change -1 pp 100% evidence | 9.2/25 ROCE 9.4% · OPM 28% 100% evidence | 4.2/20 P/E 36.7× · PEG 3.5 65% evidence | 6.4/20 RS sector -9.8% · RS bench -11.5% · 1Y -28.1%1 of 10 weeks ahead 70% evidence |
| Exact sum: 12.3 + 9.2 + 4.2 + 6.4 = 32.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24HLV LtdHLVLTD | 41.2/100Thin evidence · provisional38% evidence | 17.9/35 Revenue -26.1% · PAT 100% · OPM change — 16% evidence | 8.8/25 ROCE 7.8% · OPM -39% 60% evidence | 11.5/20 P/E 2.8× · PEG — 15% evidence | 3.0/20 RS sector -29.5% · RS bench -24.8% · 1Y -39.4%1 of 2 weeks ahead to 2026-07-19 70% evidence | |
| Exact sum: 17.9 + 8.8 + 11.5 + 3 = 41.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Royal Orchid Hotels Ltd's share price today?
Royal Orchid Hotels Ltd trades at ₹306, −39.4% over the past year. The company is valued at ₹840 Cr. The stock sits at 7% of its 52-week range of ₹291–₹513, −10.9% versus its 200-day average. On the tape, the price is in a downtrend, 37 weeks in. — as of 11 September 2026.
What were Royal Orchid Hotels Ltd's latest quarterly results?
Royal Orchid Hotels Ltd reported revenue of ₹107 Cr and net profit of ₹6.8 Cr for the Jun 26 quarter. Revenue rose 36.1% and profit fell 39.3% year on year. Earnings per share were ₹2.34. The operating margin was 23.7%, 1.2 pp lower than a year earlier. — as of 11 September 2026.
What is Royal Orchid Hotels Ltd's revenue?
Royal Orchid Hotels Ltd reported revenue of ₹107 Cr in the Jun 26 quarter, +36.1% year on year. For the full FY26 fiscal year, revenue was ₹384 Cr (+20.4%). Over the last 10 years revenue compounded at 9.2% a year. — as of 11 September 2026.
What is Royal Orchid Hotels Ltd's profit?
Royal Orchid Hotels Ltd earned ₹6.8 Cr of net profit in the Jun 26 quarter, −39.3% year on year. Full-year FY26 profit was ₹33.0 Cr. The operating margin ran 23.7% in the latest quarter. — as of 11 September 2026.
What is Royal Orchid Hotels Ltd's market cap?
Royal Orchid Hotels Ltd's market capitalisation is ₹840 Cr at a share price of ₹306. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Royal Orchid Hotels Ltd's P/E ratio?
Royal Orchid Hotels Ltd trades at a P/E of 31.5×, at the 83rd percentile of its own 8-year range, against a long-run median of 22.6×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Royal Orchid Hotels Ltd pay a dividend?
Yes — Royal Orchid Hotels Ltd's dividend payout was 21% of profit in FY26, and it recorded a payout in 6 of its last 13 reported fiscal years. 2 of those years show a negative ratio because profit itself was negative. — as of 11 September 2026.
Is Royal Orchid Hotels Ltd overvalued?
On its own history, Royal Orchid Hotels Ltd looks expensive: its P/E of 31.5× sits at the 83rd percentile of its 8-year range (long-run median 22.6×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is Royal Orchid Hotels Ltd growing?
Not right now — Royal Orchid Hotels Ltd's latest numbers are shrinking: latest-quarter revenue +36.1% year on year, profit −39.3%, and the margin −1.2 pp at 23.7%. The earnings engine currently reads: deteriorating — as of 11 September 2026.
How is Royal Orchid Hotels Ltd performing?
Royal Orchid Hotels Ltd is in a downtrend, 37 weeks in. Its latest quarter's revenue rose 36.1% and profit fell 39.3% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 14 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Royal Orchid Hotels Ltd in?
Deteriorating — profit and EPS growth are shrinking (profit growth −42.1% latest against +8.0% at its 12-quarter best), ROCE slipping at 11.0%. The read comes from the last 12 quarters of growth (revenue growth +26.9% latest, profit growth −42.1% latest, eps growth −43.9% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Royal Orchid Hotels Ltd in an uptrend?
No — the price is in a downtrend (week 37 of stage 4), trading −10.9% versus its 200-day average and at 7% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Royal Orchid Hotels Ltd beating the market?
Not lately — on a trailing-13-week view Royal Orchid Hotels Ltd is currently behind the NIFTY 500 (14 weeks and counting; last ahead the week of 2026-06-19), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +326% against the NIFTY 500's +267% — ahead of the index over the full window. — as of 11 September 2026.
Will Royal Orchid Hotels Ltd's share price go up?
This page publishes no price forecast for Royal Orchid Hotels Ltd. What it measures instead: the share price is ₹306, the price is in a downtrend 37 weeks in. Its P/E of 31.5× sits at the 83rd percentile of its own 8-year range. — as of 11 September 2026.
Who owns Royal Orchid Hotels Ltd?
Promoters hold 64.1% of Royal Orchid Hotels Ltd, foreign institutions 8.6%, domestic institutions 0.9% and the public 26.5% (latest quarter). The biggest move on the register over the last two years: Foreign institutions added 2.1 points over 8 quarters. — as of 11 September 2026.
Does Royal Orchid Hotels Ltd have too much debt?
It carries real leverage — Royal Orchid Hotels Ltd's debt-to-equity is 2.48, and operating profit covers the interest bill 2×. FY26 borrowings were ₹641 Cr against equity of ₹258 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.
What is Royal Orchid Hotels Ltd's capex?
Royal Orchid Hotels Ltd spent ₹602 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹498 Cr, with ₹2.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Royal Orchid Hotels Ltd's cash flow?
Royal Orchid Hotels Ltd generated ₹82.0 Cr of operating cash flow in FY26 and ₹−416 Cr of free cash flow after ₹498 Cr of capital spending. Reported profit that year was ₹33.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is Royal Orchid Hotels Ltd's profit real cash?
Yes — over the last 3 fiscal years, 127% of Royal Orchid Hotels Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹82.0 Cr against reported profit of ₹33.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.
Where is Royal Orchid Hotels Ltd in its business cycle?
Royal Orchid Hotels Ltd's FY26 operating margin was 23.0%, against a 13-year band of −14.0%–31.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 23.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does Royal Orchid Hotels Ltd's price assume?
At its price on 13 June 2026, Royal Orchid Hotels Ltd was priced for profit growth of about 16.7% a year. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the Royal Orchid Hotels Ltd story?
The sharpest disagreement: Foreign institutions moved +2.1 points over 8 quarters while the operating story went the other way — someone close to the numbers is not convinced. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Royal Orchid Hotels Ltd a stock worth studying right now?
This is not investment advice. The machine read: Royal Orchid Hotels Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether the register turns back in the story’s favour. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!